← Back to Search

Behavioural Intervention

Computerized Cognitive Rehabilitation for Multiple Sclerosis

N/A
Recruiting
Research Sponsored by Rutgers, The State University of New Jersey
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosis of multiple sclerosis with cognitive complaint
Be older than 18 years old
Must not have
Patients unwilling to participate
Patients with severe cognitive impairment
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Summary

This trial looks at whether a home-based computer program can help improve thinking skills in adults with multiple sclerosis, compared to a placebo group who play a videogame. Patients are assessed before and after the intervention.

Who is the study for?
This trial is for adults with multiple sclerosis who feel they're having thinking or memory problems. They must be willing to participate, able to attend testing sessions, and have some trouble on initial thinking tests in English.Check my eligibility
What is being tested?
The study is looking at a home-based computer program designed to improve thinking skills in MS patients compared to a control group playing video games. Their brain function is measured before and after the treatment.See study design
What are the potential side effects?
Since one intervention is a computerized cognitive exercise and the other is a videogame (placebo), side effects are minimal but may include eye strain, headache, or fatigue from screen time.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have multiple sclerosis and experience cognitive issues.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am willing to participate in the clinical trial.
Select...
I have severe difficulties with thinking, understanding, or remembering.
Select...
I cannot attend physical therapy sessions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Cognitive Functioning
Secondary outcome measures
Healthcare Utilization
Hospital Anxiety and Depression Scale
Multiple Sclerosis Quality of Life Inventory
+2 more
Other outcome measures
Six-minute Walk Test
Timed Up & Go Test

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: InterventionExperimental Treatment1 Intervention
Computerized Cognitive Rehabilitation
Group II: PlaceboPlacebo Group1 Intervention
Video game

Find a Location

Who is running the clinical trial?

Rutgers, The State University of New JerseyLead Sponsor
435 Previous Clinical Trials
64,943 Total Patients Enrolled
4 Trials studying Multiple Sclerosis
96 Patients Enrolled for Multiple Sclerosis
Horizon Blue Cross Blue Shield of New JerseyOTHER
3 Previous Clinical Trials
7,249 Total Patients Enrolled

Media Library

Computerized cognitive rehabilitation (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT03729713 — N/A
Multiple Sclerosis Research Study Groups: Intervention, Placebo
Multiple Sclerosis Clinical Trial 2023: Computerized cognitive rehabilitation Highlights & Side Effects. Trial Name: NCT03729713 — N/A
Computerized cognitive rehabilitation (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03729713 — N/A
Multiple Sclerosis Patient Testimony for trial: Trial Name: NCT03729713 — N/A
~19 spots leftby Jul 2025